The minimum element of a synthetic peptide required to block prostate tumor cell migration

Thomas C. Sroka, Jan Marik, Michael E. Pennington, Kit S. Lam, Anne E Cress

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Human prostate tumor cell invasion and metastasis are dependent in part on cell adhesion to extracellular matrix proteins and cell migration. We previously identified a synthetic D-amino acid tumor cell adhesion peptide called HYD1 (kikmviswkg) that supported adhesion of tumor cells derived from breast, prostate, ovary and pancreas tissue. Alanine substitution analysis and a peptide deletion strategy were used to determine the minimal element of HYD1 necessary for bioactivity in a prostate cancer cell line called PC3N. Bioactivity was measured by assays of cell adhesion, migration and ERK signaling. The most potent element of HYD1 necessary to support cell adhesion was kmvixw, the block to migration required xkmviswxx and activation of ERK signaling required ikmviswxx. The shortest sequence active in all three assays was iswkg. The HYD1 peptide contains overlapping elements required for adhesion, blocking migration and the activation of ERK signaling. These linear peptide sequences provide the starting point for development of novel compounds to target cancer cell adhesion and migration.

Original languageEnglish (US)
Pages (from-to)1556-1562
Number of pages7
JournalCancer Biology and Therapy
Volume5
Issue number11
StatePublished - Nov 2006

Fingerprint

Cell Adhesion
Cell Movement
Prostate
Peptides
Neoplasms
Cell Migration Assays
Extracellular Matrix Proteins
Alanine
Pancreas
Ovary
Prostatic Neoplasms
Breast
Neoplasm Metastasis
Amino Acids
Cell Line
lysyl-isoleucyl-lysyl-methionyl-valyl-isoleucyl-seryl-tryptophyl-lysyl-glycine

Keywords

  • Cell adhesion
  • ERK signaling
  • Migration
  • Prostate cancer
  • Synthetic peptide

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The minimum element of a synthetic peptide required to block prostate tumor cell migration. / Sroka, Thomas C.; Marik, Jan; Pennington, Michael E.; Lam, Kit S.; Cress, Anne E.

In: Cancer Biology and Therapy, Vol. 5, No. 11, 11.2006, p. 1556-1562.

Research output: Contribution to journalArticle

Sroka, TC, Marik, J, Pennington, ME, Lam, KS & Cress, AE 2006, 'The minimum element of a synthetic peptide required to block prostate tumor cell migration', Cancer Biology and Therapy, vol. 5, no. 11, pp. 1556-1562.
Sroka, Thomas C. ; Marik, Jan ; Pennington, Michael E. ; Lam, Kit S. ; Cress, Anne E. / The minimum element of a synthetic peptide required to block prostate tumor cell migration. In: Cancer Biology and Therapy. 2006 ; Vol. 5, No. 11. pp. 1556-1562.
@article{822445bb88b240a89b234ef8c2d3dd21,
title = "The minimum element of a synthetic peptide required to block prostate tumor cell migration",
abstract = "Human prostate tumor cell invasion and metastasis are dependent in part on cell adhesion to extracellular matrix proteins and cell migration. We previously identified a synthetic D-amino acid tumor cell adhesion peptide called HYD1 (kikmviswkg) that supported adhesion of tumor cells derived from breast, prostate, ovary and pancreas tissue. Alanine substitution analysis and a peptide deletion strategy were used to determine the minimal element of HYD1 necessary for bioactivity in a prostate cancer cell line called PC3N. Bioactivity was measured by assays of cell adhesion, migration and ERK signaling. The most potent element of HYD1 necessary to support cell adhesion was kmvixw, the block to migration required xkmviswxx and activation of ERK signaling required ikmviswxx. The shortest sequence active in all three assays was iswkg. The HYD1 peptide contains overlapping elements required for adhesion, blocking migration and the activation of ERK signaling. These linear peptide sequences provide the starting point for development of novel compounds to target cancer cell adhesion and migration.",
keywords = "Cell adhesion, ERK signaling, Migration, Prostate cancer, Synthetic peptide",
author = "Sroka, {Thomas C.} and Jan Marik and Pennington, {Michael E.} and Lam, {Kit S.} and Cress, {Anne E}",
year = "2006",
month = "11",
language = "English (US)",
volume = "5",
pages = "1556--1562",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "11",

}

TY - JOUR

T1 - The minimum element of a synthetic peptide required to block prostate tumor cell migration

AU - Sroka, Thomas C.

AU - Marik, Jan

AU - Pennington, Michael E.

AU - Lam, Kit S.

AU - Cress, Anne E

PY - 2006/11

Y1 - 2006/11

N2 - Human prostate tumor cell invasion and metastasis are dependent in part on cell adhesion to extracellular matrix proteins and cell migration. We previously identified a synthetic D-amino acid tumor cell adhesion peptide called HYD1 (kikmviswkg) that supported adhesion of tumor cells derived from breast, prostate, ovary and pancreas tissue. Alanine substitution analysis and a peptide deletion strategy were used to determine the minimal element of HYD1 necessary for bioactivity in a prostate cancer cell line called PC3N. Bioactivity was measured by assays of cell adhesion, migration and ERK signaling. The most potent element of HYD1 necessary to support cell adhesion was kmvixw, the block to migration required xkmviswxx and activation of ERK signaling required ikmviswxx. The shortest sequence active in all three assays was iswkg. The HYD1 peptide contains overlapping elements required for adhesion, blocking migration and the activation of ERK signaling. These linear peptide sequences provide the starting point for development of novel compounds to target cancer cell adhesion and migration.

AB - Human prostate tumor cell invasion and metastasis are dependent in part on cell adhesion to extracellular matrix proteins and cell migration. We previously identified a synthetic D-amino acid tumor cell adhesion peptide called HYD1 (kikmviswkg) that supported adhesion of tumor cells derived from breast, prostate, ovary and pancreas tissue. Alanine substitution analysis and a peptide deletion strategy were used to determine the minimal element of HYD1 necessary for bioactivity in a prostate cancer cell line called PC3N. Bioactivity was measured by assays of cell adhesion, migration and ERK signaling. The most potent element of HYD1 necessary to support cell adhesion was kmvixw, the block to migration required xkmviswxx and activation of ERK signaling required ikmviswxx. The shortest sequence active in all three assays was iswkg. The HYD1 peptide contains overlapping elements required for adhesion, blocking migration and the activation of ERK signaling. These linear peptide sequences provide the starting point for development of novel compounds to target cancer cell adhesion and migration.

KW - Cell adhesion

KW - ERK signaling

KW - Migration

KW - Prostate cancer

KW - Synthetic peptide

UR - http://www.scopus.com/inward/record.url?scp=33846958061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846958061&partnerID=8YFLogxK

M3 - Article

C2 - 17102593

AN - SCOPUS:33846958061

VL - 5

SP - 1556

EP - 1562

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 11

ER -